BrightInsight Announces $101M in Series C Funding!
Led by General Catalyst, the Financing will Fuel BrightInsight’s Hypergrowth as the Leading Global Regulated Digital Health Platform for Biopharma and Medtech
Learn More
Our BrightInsight Platform is built under a Quality Management System to support and optimize up to Class III regulated drugs, devices, software, connected surgical equipment and Digital Therapeutics through integrated data and actionable insights
Hit the ground running with our managed service model, modular platform architecture and foundational capabilities.
Our integrated data management transforms drug and device data into powerful real-time insights.
Our advanced quality, security, privacy and compliance processes and tools give you peace of mind.
Led by General Catalyst, the Financing will Fuel BrightInsight’s Hypergrowth as the Leading Global Regulated Digital Health Platform for Biopharma and Medtech
Learn More
Using a regulated infrastructure alleviates regulatory concerns as you’re developing your product over years and years. You can be confident that from an infrastructure standpoint, you’ll be compliant.
- Bradley Merrill Thompson, Epstein Becker & Green, P.C.
CSL Behring selects the BrightInsight Platform to build and manage its digital health solutions within a regulatory-compliant environment.
Learn More
Download our webinar to hear Paul Upham, Head of Smart Devices at Roche/Genentech, discuss how Roche launched a regulated SaMD dosing calculator for treating Hemophilia A.
Download